Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy

被引:0
|
作者
Feng Huang [1 ]
Jian Gao [2 ]
机构
[1] Second Clinical College, Chongqing Medical University
[2] Department of Gastroenterology, Second Affiliated Hospital, Chongqing Medical University
基金
中国国家自然科学基金;
关键词
Modified Child-Pugh grade; Albumin-Bilirubin grade; Hepatocellular carcinoma; Prognosis; Hepatectomy; Child-Pugh;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Hepatectomy is the main treatment for patients with hepatocellular carcinoma(HCC) and it has a high possibility for long-term cure potential. But the postoperative mortality and recurrence rates remain high. Since the long-term prognosis of HCC patients is strongly linked to liver function, preoperative assessment of liver function is very important for HCC patients.AIM To compare the predictive power of the modified Child-Pugh(MCP) and albumin-bilirubin(ALBI) grades for the long-term outcome of HCC.METHODS From January 2010 to June 2017, a total of 204 patients with HCC who underwent surgery at the Second Affiliated Hospital of Chongqing Medical University were enrolled in this retrospective study. Multivariate Cox regression analysis was used to determine the independent predictive factors of survival and relapse. The area under the curve(AUC) was used to evaluate the discriminative performance of the MCP grade and ALBI grade to predict the postoperative overall survival(OS) time and recurrence-free survival(RFS) time.RESULTS The median OS and RFS times were 44.0 mo(range: 22.0-74.0 mo) and 22.0 mo(range: 5.0-45.0 mo), respectively. The median OS and RFS times of MCP grades1, 2, and 3 patients were 60.0, 39.0, and 18.0 mo(P < 0.001) and 36.0, 15.0, and 7.0 mo(P < 0.001), respectively. The median OS and RFS times of ALBI grades 1, 2,and 3 patients were 56.0, 26.0, and 6.0 mo(P < 0.001) and 25.0, 10.0, and 3.0 mo(P= 0.003), respectively. Both the MCP and ALBI grades were more accurate than the Child-Pugh grade for predicting long-term prognosis. Further analysis demonstrated that for both predicting OS and RFS, the MCP grade performed better than the ALBI grade(AUC: 0.642 vs 0.605 for OS; 0.659 vs 0.594 for RFS).CONCLUSION The MCP grade is more accurate than the ALBI grade for predicting long-term outcome of patients with HCC.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 50 条
  • [21] Post-operative albumin-bilirubin grade predicts long-term outcomes among Child–Pugh grade A patients with hepatocellular carcinoma after curative resection
    Masataka Amisaki
    Ei Uchinaka
    Masaki Morimoto
    Naruo Tokuyasu
    Teruhisa Sakamoto
    Soichiro Honjo
    Hiroaki Saito
    Yoshiyuki Fujiwara
    Hepatobiliary&PancreaticDiseasesInternational, 2018, 17 (06) : 502 - 509
  • [22] ALBI GRADE VS. CHILD-PUGH GRADE AS A GRADING SYSTEM FOR LIVER FUNCTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Jung, Y. K.
    Na, S. K.
    Suh, S. J.
    Yim, H. J.
    Kim, S. Y.
    Hyun, J. J.
    Jung, S. W.
    Koo, J. S.
    Kim, J. H.
    Seo, Y. S.
    Yeon, J. E.
    Lee, S. W.
    Byun, K. S.
    Um, S. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S343 - S344
  • [23] Evaluation of Pretreatment Albumin-Bilirubin Grade as a Better Prognostic Factor than Child-Pugh Classification in Hepatocellular Carcinoma Patients Administered Transarterial Chemoembolization Combined with Radiotherapy
    Lee, J. J. B.
    Lee, H.
    Nam, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E176 - E176
  • [24] Evaluation of Pretreatment Albumin-Bilirubin Grade as a Better Prognostic Factor Compared to Child-Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy
    Lee, Jason Joon Bock
    Park, Jun Su
    Hong, Hyun Pyo
    Kim, Myung Sub
    Koo, Dong-Hoe
    Lee, Hyebin
    Nam, Heerim
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [25] Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
    Ni, Jia-Yan
    Fang, Zhu-Ting
    An, Chao
    Sun, Hong-Liang
    Huang, Zhi-Mei
    Zhang, Tian-Qi
    Jiang, Xiong-Ying
    Chen, Yao-Ting
    Xu, Lin-Feng
    Huang, Jin-Hua
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 (01) : 841 - 853
  • [26] Prognostic Value of Platelet-Albumin-Bilirubin Grade in Child-Pugh A and B Patients With Hepatocellular Carcinoma: A Meta-Analysis
    Liu, Rongqiang
    Li, Rongqi
    Zhang, Min
    Liu, Wenbin
    Li, Hui
    Li, Dewei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia
    Man, Zhong-Ran
    Gong, Xuan-Kun
    Qu, Kang-Lin
    Pang, Qing
    Wu, Bin-Quan
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (05) : 1763 - 1772
  • [28] Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment
    Hu, Keshu
    Yuan, Jia
    Tang, Bei
    Zhang, Feng
    Lu, Shenxin
    Chen, Rongxin
    Zhang, Lan
    Ren, Zhenggang
    Yin, Xin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [29] Albumin-Bilirubin Versus Child-Pugh Score as a Predictor of Survival After Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
    Ho, C. H.
    Chiang, C. L.
    Lee, F. A.
    Chan, J. C.
    Yeung, C. S. Y.
    Choi, C. K.
    Wong, F. C.
    Tung, S. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E153 - E153
  • [30] COMBINATION OF MODIFIED ALBUMIN-BILIRUBIN GRADE AND PLATELET COUNT TO PREDICT VARICES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Ananchuensook, Prooksa
    Piyawannasuth, Kingkomon
    Suksawatamnuay, Sirinporn
    Thaimai, Panarat
    Siripon, Nipaporn
    Sriphoosanaphan, Supachaya
    Thanapirom, Kessarin
    Komolmit, Piyawat
    GASTROENTEROLOGY, 2024, 166 (05) : S59 - S59